Abstract
The pharmacokinetic characteristics of tiagabine are described and the interaction effects of concomitant antiseizure medications on tiagabine in terms of its pharmacokinetics and pharmacodynamics are highlighted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
So EJ, Wolff D, Graves NM, Leppik IE, Cascino GD, Pixton GC, Gustavson LE. Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme inducing antiepilepsy drugs. Epilepsy Res. 1995;22:221–6.
Bockbrader HN, Burger P, Knapp L. Pregabalin effect on steady-state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. Epilepsia. 2011;52:405–9.
Wang X, Patsalos PN. The pharmacokinetic profile of tiagabine. Rev Contemp Pharmacother. 2002;12:225–34.
Leach JP, Brodie MJ. Synergism with GABAergic drugs in refractory epilepsy. Lancet. 1994;343:1650.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Patsalos, P.N. (2022). Tiagabine. In: Antiseizure Medication Interactions. Springer, Cham. https://doi.org/10.1007/978-3-030-82790-8_29
Download citation
DOI: https://doi.org/10.1007/978-3-030-82790-8_29
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-82789-2
Online ISBN: 978-3-030-82790-8
eBook Packages: MedicineMedicine (R0)